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The deployment device 
slowly blowing up the 
balloon to expand the 
new valve. The three 
cusps are lined up in the 
coplanar view so the 
valve does not occlude 
any of the coronaries. 
The balloon blown up 
as the heart is being 
paced at about 180 
bpm. Once the balloon 
is blown up, it is held up 
for about 5 seconds, 
then it is deflated and 
the deployment device 
is removed. 
Conclusion:
In conclusion, TAVR is continuing to 
evolve and become more sufficient for 
patients compared to open heart surgery. 
It proceeds to create new aortic valves 
and it is a good option for high risk 
patients to have cardiac surgery.
Two Types of Valves: 
Statistics for Survival:
Outcomes:
Successful therapeutic intervention for 
high-risk patients
• Primary outcome was risk-adjusted 
mortality at 30 days
• Secondary outcomes included a 30-day 
composite complication outcome
• (stroke, moderate or severe 
paravalvular leak, major 
vascular access-site 
complications or Valve 
Academic Research 
Consortium major or life-
threatening or disabling 
bleeding, or acute kidney 
injury)
(Vemulapalli, S., MD, et al., 2019)
Concerns About TAVR:
• 1. The data are too short-term, and 
patients might need surgery later.
• 2. TAVR in low-risk patients is not yet 
FDA-approved, but patients want it 
now.
• 3. Benefits of TAVR may not balance 
potential long-term risks. 
(Kumbhani, D., MD., 2019)
Introduction:
Transcatheter aortic valve replacement 
(TAVR) “is a cardiac intervention first 
introduced in 2002 to provide treatment for 
high-risk patients requiring standard 
surgical interventions” 
(Siordia JA, Skaria R, and Subramanian S., 2016)
About Cardiac Catheterization:
• “Modality that requires a minor surgical 
procedure involving the introduction of 
specialized catheters into the heart and 
surrounding vasculature”
• “Done for the purpose of diagnostic 
evaluation and therapy associated with 
various cardiovascular-related disorders 
in children and adults”
• “Cardiac Cath is a procedure that is 
performed to test a hearts function”
Long, B. W., Rollins, J. H., and Smith, B. J. (2019)
Kaplan Meier survival curves for 
patients < 80 vs. ≥ 80 years old. This 
graph showed a “mean survival (41.0 ±
2.1 vs. 38.2 ± 2.2 months, respectively, 
P = 0.18” 
(Kahraman Ay N., 2019) 
Transfemoral Approach:
(Havrda, J. B., and Paterson, E., 2019)
Steps of TAVR:












1. Get access 
(artery/vein)
2. Insert pacemaker
3. Find coplanar 
view (RCC, NCC, 
and LCC all in 
same plane)
4. Cross aortic valve
5. Pre-treat aortic 
valve (if needed)
6. Prep valve 
delivery device







devices to close 
up
In picture A, the doctor needs to assure 
that the valve sits in the coplanar view. In 
picture B, a couple steps occur while the 
valve is being deployed. They are: pacer 
on, inject, inflate, deflate, pacer off. In 
image C, the valve is completely deployed 
and the equipment is removed from the 
body.
Advantages of TAVR:
• Quicker recovery times
• Less invasive than open heart surgery
• Minimal sedation, conscious sedation 
compared to general anesthesia for 
open heart
Reason for a TAVR
• Aortic Stenosis (AS)
• Narrowing of aortic valve, 
limiting blood flow to body
• Causes of AS
o “3 known causes of AS-
rheumatic disease, calcific 
disease, and congenital valve 
disease”
o (Lauck, S., Perpetua, E. M., Hawkey, M.
C., and Simone, A., 2019) 
Cardiac 
Cath Lab






(Vahl, Kodali, and Leon, 2016)
(Kumbhani, D., MD., 2019)  
• Micro-puncture kit is 
used to get access
• Wires/catheters go 
in femoral 
artery/vein all the 
way to the heart
(Geisinger Community Medical Center, 2021) 
Balloon-expandable Self-expandable
• Only two commercially approved 
valves in the United States
• Intermediate, high, and extreme risk
• Valve-in-valve
